This feature is available to journalist, bloggers and other members of the media. You must be logged into ReleaseWire to take advantage of this service.
Posted on Wednesday, October 12, 2022 at 11:45 am CDT
Druglike, a Web3 drug discovery software platform co-founded by Martin Shkreli, today released a demo, website, and whitepaper detailing its efforts to democratize the costs, access, and rewards of computational drug discovery.